Scarica l'app Stockscreener
3.78
5.59%
0.20
Dopo l'orario di chiusura:
3.64
-0.14
-3.70%
Larimar Therapeutics Inc Borsa (LRMR) Ultime notizie
Larimar Therapeutics: Institutional Confidence and Capital-Raising Strategy Signal Conviction in Long-Term Pipeline - AInvest
Institutional Investors Hold 40% Stake in Larimar Therapeutics - AInvest
With 40% stake, Larimar Therapeutics, Inc. (NASDAQ:LRMR) seems to have captured institutional investors' interest - Yahoo Finance
Larimar Therapeutics Aligns with FDA Guidance, Revises Nomlabofusp Submission Timeline - MSN
Larimar Therapeutics Sees Significant Stock Purchase by Director - AInvest
Larimar Therapeutics Stock (LRMR) Opinions on Public Offering Announcement - Quiver Quantitative
Mintz Advises on Larimar Therapeutics’ $69 Million Public Offering - Mintz
Larimar Therapeutics Insider Bought Shares Worth $30,000,000, According to a Recent SEC Filing - MarketScreener
Massive Stock Purchase by Larimar Therapeutics Director! - TipRanks
Larimar therapeutics: Deerfield funds buy $10.8m in shares By Investing.com - Investing.com Canada
Larimar therapeutics: Deerfield funds buy $10.8m in shares - Investing.com India
Larimar Therapeutics stock price target lowered to $10 at Jones Trading - Investing.com Canada
Why is Larimar Therapeutics Inc. stock attracting strong analyst attentionCapitalize on high-growth stocks early - Jammu Links News
What analysts say about Larimar Therapeutics Inc. stockCapitalize on high-yield stocks early - Jammu Links News
What institutional investors are buying Larimar Therapeutics Inc. stockAchieve exceptional returns with expert guidance - Jammu Links News
What catalysts could drive Larimar Therapeutics Inc. stock higher in 2025Build wealth steadily with expert advice - Jammu Links News
How does Larimar Therapeutics Inc. compare to its industry peersBuild a portfolio that withstands market volatility - Jammu Links News
What are analysts’ price targets for Larimar Therapeutics Inc. in the next 12 monthsUnmatched profit potential - Jammu Links News
Should I hold or sell Larimar Therapeutics Inc. stock in 2025Discover stocks with strong growth potential - Jammu Links News
Is Larimar Therapeutics Inc. a good long term investmentCapitalize on market shifts before others do - Jammu Links News
What are the technical indicators suggesting about Larimar Therapeutics Inc.Unlock powerful market insights for success - Jammu Links News
What are Larimar Therapeutics Inc. company’s key revenue driversDiscover breakthrough stocks before the crowd - Jammu Links News
Larimar Therapeutics Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView
Larimar Therapeutics raises $69 million in public offering - Investing.com
Larimar Therapeutics raises $69 million in public offering By Investing.com - Investing.com Nigeria
Larimar Therapeutics Announces $64.4 Million Stock Offering - The Globe and Mail
Why Larimar Therapeutics Inc. is moving todayAutomated AI Forecast with Trading Alerts - Newser
Relative strength of Larimar Therapeutics Inc. in sector analysisSmart Trade Mapping with Entry Details - Newser
Analyzing recovery setups for Larimar Therapeutics Inc. investorsOversold Reversal Picks with Buy Zone - Newser
Larimar Therapeutics Raises $64.4 Million in Stock Offering - AInvest
Short interest data insights for Larimar Therapeutics Inc.Free Real-Time Market Sentiment Tracking Tool - Newser
Larimar Therapeutics Announces Closing of Underwritten - GlobeNewswire
Larimar Therapeutics Announces Closing of Underwritten Public Of - GuruFocus
Larimar Therapeutics Closes $69 Million Public Offering of Common Stock to Support Development of Pipeline Candidates - Quiver Quantitative
Larimar Therapeutics Raises $69M in Oversubscribed Public Offering - AInvest
Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares - GlobeNewswire
Rare Disease Biotech Larimar Secures $69M Windfall as Investors Rush to Oversubscribed Stock Offering - Stock Titan
Using R and stats models for Larimar Therapeutics Inc. forecastingShort-Term AI-Based Stock Price Forecast - Newser
What recovery options are there for Larimar Therapeutics Inc.Free High Win Rate Trading Opportunities - Newser
What indicators show strength in Larimar Therapeutics Inc.Predictive System for Long-Term Stock Forecast - Newser
Is it time to cut losses on Larimar Therapeutics Inc.Conservative Entry for High Return Setup Backed - metal.it
Is Larimar Therapeutics Inc. stock overhyped or has real potentialFree Trade Setups With AI Powered Filters - Newser
Will Larimar Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsReal Time Trade Opportunity Alerts Monitor Market Surges - metal.it
Larimar Therapeutics Announces Public Offering, Drops 20% in Share Price - AInvest
Larimar Therapeutics stock falls after $60 million public offering By Investing.com - Investing.com Canada
Larimar Therapeutics falls after $60 mln equity raise - TradingView
Multi asset correlation models including Larimar Therapeutics Inc.Free Breakout Momentum Picks With Protection - Newser
Larimar Therapeutics launches public offering of common stock - Investing.com India
Larimar Therapeutics Inc. Stock Support and Resistance Levels You Should KnowIntelligent Trade Forecast With AI Analytics - Newser
1.02%
3.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):